Is There a Post-COVID Dermatological Syndrome? The Integrated Dermato-Infectious Disease Experience of a Single Centre

    November 2021 in “ Journal of the European Academy of Dermatology and Venereology ”
    Federico Diotallevi, Sara Mazzanti, P Properzi … Annamaria Offidani
    Studysummary This study observed that telogen effluvium is the most frequent and specific dermatological manifestation in patients with long COVID syndrome following severe SARS-CoV2 infection.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management JAAD International · 2021
    2. Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience Dermatologic Therapy · 2020
    3. Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature Drugs - Real World Outcomes · 2016
    4. Chronic Telogen Effluvium Is Due to a Reduction in the Variance of Anagen Duration Australasian Journal of Dermatology · 2010